巴基斯坦信德省9月龄至15岁儿童伤寒结合疫苗补种活动的现场效果评估
在巴基斯坦信德省卡拉奇和海得拉巴的补种活动中,对9月龄至15岁儿童开展伤寒结合疫苗(TCV)现场效果评估,纳入968例血培养确诊伤寒病例,采用快速筛查法计算疫苗有效性(VE)。基于EPI提供的TCV覆盖率数据,VE为98%。作者认为TCV有效,但改善环境卫生和个人卫生对预防肠道热传播仍是必要的,且需更长期随访评估保护持久性和加强剂次需求。
要点
- 补种活动中基于EPI覆盖率数据计算的TCV疫苗有效性为98%。
- 968例培养确诊伤寒病例中,61%为广泛耐药(XDR),6%为多重耐药(MDR)。
- 作者认为改善环境卫生和卫生条件对预防肠道热传播是必要的。
核心结论
- TCV在补种活动背景下对9月龄至15岁儿童培养确诊的伤寒沙门菌有效。
- 作者认为伤寒疫苗接种可显著降低伤寒疾病负担,但改善环境卫生和卫生条件对预防肠道热传播是必要的。
- 作者指出需要更长期随访以评估TCV的保护持久性和加强剂次需求。
研究设计与样本
- 在巴基斯坦信德省卡拉奇和海得拉巴开展的TCV补种活动(2019年11月)现场效果评估。
- 通过卡拉奇和阿加汗大学医院、卡拉奇Kharadar综合医院及海得拉巴Liaqat医学与健康科学大学(LUMHS)的实验室网络识别年龄符合条件且血培养确诊伤寒沙门菌的病例。
- 使用结构化问卷收集社会人口学、伤寒疫苗接种史和抗菌药物耐药信息,并查阅患者病历和实验室报告。
- 从省级EPI办公室获取补种活动期间人群疫苗接种覆盖率数据。
- 采用快速筛查法计算疫苗有效性(VE)。
主要发现
- 共纳入968例培养确诊伤寒病例,其中82%(793/968)来自卡拉奇,18%(175/968)来自海得拉巴。
- 参与者平均年龄为5.68岁,54%(523/968)为男性。
- 6%(62/968)的培养确诊伤寒沙门菌病例为多重耐药(MDR),61%(586/968)为广泛耐药(XDR)。
- 基于EPI提供的TCV覆盖率数据,VE为98%。
局限性
- 作者指出需要更长期随访以评估TCV的保护持久性和加强剂次需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Typhoid conjugate vaccine (TCV) has recently been introduced in the expanded program for immunization (EPI) in Pakistan. Before its introduction in routine immunization, a onetime catchup campaign among children 9 months to 15 years old was conducted in November 2019. We performed field evaluation of TCV against culture confirmed Salmonella Typhi (S. Typhi) among 9 months to 15 years old children during the catch up campaign in Karachi and Hyderabad. METHODS: A rapid assessment of blood culture confirmed S. Typhi was performed. Age eligible cases of culture confirmed S. Typhi were identified from the laboratory networks of Aga Khan University Hospital Karachi and Hyderabad, Kharadar General Hospital Karachi, and Liaqat University of Medical & Health Sciences (LUMHS) Hyderabad. Information on sociodemographic, typhoid vaccination history and antimicrobial resistance was collected using a structured questionnaire. Patient medical records and lab reports were also reviewed to collect information on diagnosis and antimicrobial susceptibility information. Information about the population vaccination coverage during catch-up campaign was obtained from the provincial EPI office. Field performance of TCV in catchup campaign was measured by calculating the effectiveness using rapid screening method which is less resource-intensive technique of calculating vaccine effectiveness (VE). RESULTS: Overall, 968 culture confirmed typhoid cases were enrolled. Among them, 82% (793/968) were from Karachi and 18% (175/968) from Hyderabad. The average age of the participants was 5.68 years, and 54% (523/968) were male. 6% (62/968) of the culture confirmed S. Typhi cases were multidrug resistant (MDR), and 61% (586/968) were extensively drug resistant (XDR). The VE using the TCV coverage data provided by EPI was 98%. CONCLUSION: TCV is effective against culture confirmed S. Typhi among children aged 9 months to 15 years in the catch-up campaign setting. While typhoid vaccination can significantly decrease the burden of typhoid disease, improvements in sanitation and hygiene are necessary for the prevention of spread of enteric fever. Longer term follow up will be needed to assess the duration of protection and requirement for booster doses of TCV.
引用
- Thobani RS, Yousafzai MT, Sultana S, et al. Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan. Vaccine. 2022. PMID: 35945044. doi:10.1016/j.vaccine.2022.06.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。